WHY IT MATTERS: Patients relying on medical cannabis for serious conditions may see improved access, more consistent product standards, and stronger legal protections if compassionate care policy reforms move forward at the federal level. CLINICAL OVERVIEW: Efforts to modernize medical cannabis policy at a national level reflect a growing recognition that patients deserve structured, evidence-informed access to cannabinoid therapies rather than navigating a fragmented and inconsistent regulatory landscape. Compassionate care frameworks have historically served as critical pathways for patients with serious or treatment-resistant conditions to access medications outside of standard channels.
Cannabis and Cardiovascular Health: 7 Things the JAMA Study Missed
A new JAMA study raised eyebrows about cannabis and cardiovascular health—but does it actually raise red flags? We break down what it measured, what it missed, and why most headlines are skipping the fine print. This is your physician-filtered guide to separating concern from clickbait.
5 Exciting Insights from the MedCan 3 Trial
MedCan 3: A Landmark Study on Medicinal Cannabis for Cancer Symptom Management Read The Study Publication The MedCan 3 study is a highly anticipated clinical trial investigating the potential of...
Finding a New Medical Cannabis Provider in Massachusetts: CED Clinic Welcomes Patients from Retiring and Deceased Doctors
Finding a New Medical Cannabis Provider in Massachusetts: CED Clinic Welcomes You with Open Arms If you’re searching for a new medical cannabis provider in Massachusetts, we understand that this might be...